TP53 and neoplasm: In addition to increased expression of apoptosis inhibitors known as IAPs, decreased caspase expression, defects, and mutations in the tumor suppressor p53, which upregulates proapoptotic proteins and significantly influences the metabolism of tumor cells, are also involved in cell resistance to apoptosis [144,145].